USPTO serial 78258657
CEREPRO
Reviewed by CopyMark Law Group
Reg. 3301634Status 710
- Filing date
- Status date
- Registration date
- Oct 2, 2007
- Examiner
- OSBORNE, STANLEY
- Law office
- TMEG LAW OFFICE 102
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CEREPRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
FINVECTOR VISION THERAPIES LTD
CHINNOR, OXFORDSHIRE, GB
FINVECTOR VISION THERAPIES LTD
CHINNOR, OXFORDSHIRE, GB
London, GB
London, GB
London, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ronald E. Shapiro
Ronald E. Shapiro Shapiro and Silverstein PLLC11350 Random Hills Road, Suite 740Fairfax, VA 22030UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF MALIGNANT GLIOMA AND OTHER MALIGNANT BRAIN TUMORS; PHARMACEUTICAL PREPARATIONS IN THE NATURE OF VIRAL VECTORS FOR THE TREATMENT OF CANCER, CANCER VACCINES; PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY(Based on 44(d) Priority Application) PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF MALIGNANT GLIOMA AND OTHER MALIGNANT BRAIN TUMORS; PHARMACEUTICAL PREPARATIONS IN THE NATURE OF VIRAL VECTORS FOR THE TREATMENT OF CANCER, CANCER VACCINES; PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FINVECTOR VISION THERAPIES LTD
- Other trademarks owned by FINVECTOR VISION THERAPIES LTD
- Other trademarks owned by Ark Therapeutics Limited
- Other trademarks owned by Ark Therapeutics Limited
- Other trademarks owned by Ark Therapeutics Limited
- Other trademarks in Class 005
- Similar marks named CEREPRO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 4, 2018 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Oct 2, 2016 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 18, 2013 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 18, 2013 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Sep 18, 2013 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Sep 18, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 17, 2013 | 8.AF | REGISTERED - SEC. 8 (6-YR) FILED | — |
| Sep 17, 2013 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Oct 2, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 17, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 27, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 12, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 12, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 29, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 26, 2007 | ALIE | ASSIGNED TO LIE | — |
| May 10, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2006 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 17, 2006 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 30, 2006 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 31, 2006 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 31, 2006 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 28, 2005 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 16, 2005 | DMCC | DATA MODIFICATION COMPLETED | — |
| Sep 8, 2005 | PAPER RECEIVED | — | |
| Apr 26, 2005 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 26, 2005 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 31, 2005 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 18, 2004 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 29, 2004 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 30, 2004 | EMRV | EMAIL RECEIVED | — |
| Jan 29, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 27, 2003 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 19, 2003 | DOCK | ASSIGNED TO EXAMINER | — |